CALLICUTT JACK W bought GALT
November 5, 2025 · Form 4 insider transaction
CALLICUTT JACK W bought 200 shares of Galectin Therapeutics Inc. at $1.98 per share, a transaction worth $396.00. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
200
Price
$1.98
Total value
$396.00
InsiderCALLICUTT JACK W
RoleOfficer
SecurityCommon stock
Transaction codeM: Option exercise
Transaction dateNovember 5, 2025
Filing dateNovember 7, 2025
Shares owned after7,814
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The reported transaction was made pursuant to a Rule 10b5-1 plan adopted by the reporting person on April 17, 2025, as disclosed in the Issuer?s Quarterly Report on Form 10-Q, filed with the SEC on August 14, 2025.